Eiko Lifesciences Limited announces 2:3 rights issue

The Right Issue Committee of the Board of Directors of Eiko Lifesciences Limited at their meeting held on May 15, 2023, have considered and approved the terms of the Rights Issue.

The committee approved issuances of 55,44,178 partly paid Partly Paid-up Equity Shares of face value of Rs. 10/- each at an issue price of Rs. 45/- per Equity Share (including a premium of Rs. 35/- per Equity Share) aggregating to Rs. 2,494.88 Lakhs to all the existing equity shareholders of the Company on a rights basis ("Rights Issue").

Right entitlement ratio: 2 (Two) Equity Share for every 3 (Three) Fully Paid Equity Shares held by the Existing Shareholders on the record date.

Rights Issue Price: Rs. 45/- per Rights Equity Share (including a premium of Rs. 35/- per Rights Equity Share). The amount of Rs. 13.5 per Rights Equity Share (Face Value = ₹ 3/- and Premium = ₹10.5/-) to be paid on Application and balance to be paid in not more than two calls as determined by our Board at its sole discretion from time to time.

Outstanding Equity Shares:

Prior to the Rights Issue: 83,16,267 Equity shares;
Post Rights Issue: *1,38,60,445 Equity Shares.

Shares of Narendra Investments (Delhi) Ltd was last trading in BSE at Rs. 76.23 as compared to the previous close of Rs. 75.87. The total number of shares traded during the day was 32518 in over 142 trades.

The stock hit an intraday high of Rs. 76.99 and intraday low of 75.00. The net turnover during the day was Rs. 2464496.00.

Source : Equity Bulls

Keywords

EIKOLifesciences INE666Q01016 RightsIssue FundRaising RecordDate